期刊文献+

老年高血压伴肥胖患者血清MMP-9、MCP-1水平的变化及其临床意义的研究 被引量:5

Study on the changes and clinical significance of serum MMP-9,MCP-1 level in elderly patients with hypertension and obesity
下载PDF
导出
摘要 目的探讨老年高血压伴肥胖患者血清基质金属蛋白酶-9(MMP-9)、单核细胞趋化因子-1(MCP-1)水平的变化及其临床意义。方法将符合纳入、排除标准的高血压患者分为高血压肥胖组和单纯高血压组,正常血压者分为单纯肥胖组和正常对照组。高血压的诊断依据2005年中国高血压防治指南诊断标准,肥胖诊断依据按BMI≥25 kg/m2(亚太地区标准)。对所有受试者进行一般检查及血糖、血脂等生化检查,Elisa法测定血清MCP-1和MMP-9水平。结果①单纯肥胖组、单纯高血压组、高血压肥胖组BMI、TG、LDL-C均较对照组升高,差异有统计学意义(P<0.05);单纯肥胖组、单纯高血压组、高血压肥胖组HDL-C均较对照组降低,差异有统计学意义(P<0.05);单纯高血压组、高血压肥胖组FPG、SBP、DBP均较对照组增高,差异有统计学意义;高血压肥胖组和单纯高血压组BMI、SBP、DBP较单纯肥胖组增高,差异有统计学意义(P<0.05);高血压肥胖组BMI、FPG、TG、TC较单纯高血压组增高,差异有统计学意义(P<0.05)。②MMP-9和MCP-1水平在对照组、单纯肥胖组、单纯高血压组和高血压肥胖组中逐渐增高,且单纯肥胖组、单纯高血压组、高血压肥胖组和对照组比较,单纯高血压组、高血压肥胖组和单纯肥胖组比较,高血压肥胖组和单纯高血压组比较,差异均有统计学意义(P<0.05)。结论血清MMP-9、MCP-1在肥胖及动脉粥样硬化进程中具有重要意义,可能加速高血压肥胖患者动脉粥样硬化进程。 Objective To investigate the changes and clinical significance of serum MMP-9,MCP-1 in elderly patients with hypertension and obesity.Methods According to bringing and removing standard option,subjects were classified as control group、simple obesity group、simple hypertension group and obesity-associated hypertension group.Diagnosis of hypertension under the guidance of China hypertension diagnostic criteria in 2005,diagnosis of obesity by body mass index according to BMI ≥25 kg/m2(Asia-Pacific standards).A general examination and conventional blood glucose,blood lipids and other biochemical tests were detected in all subjects,serum concentrations of MMP-9 and MCP-1 levels was measured by the Elisa method.Results (1) BMI,TG,LDL-C in control group,simple obesity group,simple hypertension group and obesity-associated hypertension group,were increased gradually,and compare each of them there is a statistical significance(P〈0.05);HDL-C in control group,simple obesity group,simple hypertension group and obesity-associated hypertension group,were decreased gradually,and compare each of them there is a statistical significance(P〈0.05);FPG,SBP,DBP in simple hypertension group and obesity-associated hypertension group higher than control group,and compare each of them there is a statistical significance(P〈0.05);BMI,SBP,DBP in simple hypertension group and obesity-associated hypertension group higher than simple obesity group,and compare each of them there is a statistical significance(P〈0.05);BMI,FPG,TG,TC in obesity-associated hypertension group higher than simple hypertension group,and compare them there is a statistical significance(P〈0.05);(2) serum MMP-9 and MCP-1 concentrations in control group,simple obesity group,simple hypertension group and obesity-associated hypertension group,were increased gradually,and compare each of them there is a statistical significance(P〈0.05).Conclusion MMP-9 and MCP-1 play very important role in the process of obesity and astherosclerosis and also can accelerate astherosclerosis.
出处 《中国实验诊断学》 北大核心 2011年第9期1510-1513,共4页 Chinese Journal of Laboratory Diagnosis
  • 相关文献

参考文献10

  • 1Yu X,Dluz S,Graves DT,et al.Elevated expression of monocyte chemoattractant protein 1 by vascular smooth muscle cells in hypercholesterolemic primates[J].Proc Natl Acad Sci U S A,1992,89:6953.
  • 2Steinberg D.Lewis A.Conner Memorial Lecture.Oxidative modification of LDL and atherogenesis[J].Circulation,1997,95:1062.
  • 3Grewal IS,Rutledge BJ,Fiorillo JA,et al.Transgenic monocyte chemoattractant protein-1 (MCP-1) in pancreatic islets produces monocyte-rich insulitis without diabetes.Abrogation by a second transgene expressing systemic MCP-1[J].J Immunol,1997,159:401.
  • 4Aiello RJ,Bourassa P-AK,Lindsey S,et al.Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice[J].Arterioscler Thromb Vasc Biol,1999,19:1518.
  • 5Gu L,Okada Y,Clinton SK,et al.Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice[J].Mol Cell,1998,2:275.
  • 6Gosling J,Slaymaker S,Gu L,et al.MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B[J].J Clin Invest,1999,103:773.
  • 7Boring L,Gosling J,Cleary M,Charo IF.Decreased lesion formation in CCR2-/-mice reveals a role for chemokines in the initiation of atherosclerosis[J].Nature,1998,394:894.
  • 8Dawson TC,Kuziel WA,Osahar TA,et al.Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice[J].Atherosclerosis,1999,143:205.
  • 9Ridker PM,Rifai N,Rose L,et al.Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events[J].N Engl J Med,2002,347:1557.
  • 10De Lemos JA,Morrow DA,Sabatine MS,et al.Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes[J].Circulation,2003,107:690.

同被引文献52

  • 1王从杰,孙静,张志珺.抗精神病药与2型糖尿病[J].临床精神医学杂志,2004,14(5):313-314. 被引量:18
  • 2赵丽,张翥.AngⅡ介导的高血压炎症反应机制[J].高血压杂志,2005,13(9):533-536. 被引量:11
  • 3李晓霞,韩阳.炎症细胞因子与高血压[J].高血压杂志,2006,14(6):426-428. 被引量:25
  • 4Mueneh J, Hamer AM. Adverse effects of antipsychotic medi- cations[J]. Am Faro Physician, 2010,81 (5) : 617 - 622.
  • 5Sartipy P, Loskutoff DJ. Monocyte chemoattractant protein 1 in obesity and insulin resistanee[J]. Proe National Acad Sci U S A,2003,100(12) :7 265-7 270.
  • 6Cope MB, Nagy TR, Fernandez JR, et al. Antipsychotic drug -induced weight gain: development of an animal model[J].Int J Obes(Lond),2005,29(6):607-614.
  • 7高燕燕.不同药物对高脂饮食诱导肥胖大鼠Ghrelin、TNF-a、Adiponectin、MCP-1的影响[M].济南:山东大学,2006.
  • 8饶子亮,钟志勇,谢超敏,等.高脂饲料诱导肥胖大鼠和肥胖小鼠模型的比较研究[G].In:第九届中国实验动物科学年会论文集,2010.
  • 9Dubuc PU. The development of obesity, hyperinsulinemia, and hyperglycemia in ob/ob mice[J]. Metabolism, 1976,25 (12):I 567-1 574.
  • 10Pramyothin P, Khaodhiar L. Metabolic syndrome with the a- typical antipsychotics[J]. Curr ()pin Endocrinol Diabet Obesi- ty,2010,17(5) :460-466.

引证文献5

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部